Successful tenofovir treatment for fulminant hepatitis B infection in an infant

Pediatric Infectious Disease Journal

Volumn 30, Issue 10, 2011, Pages 912-914

  Diamanti, Antonella ^a   Sartorelli, Maria Rita ^a   Alterio, Arianna ^a   Comparcola, Donatella ^a   Corsetti, Tiziana ^a   Iacono, Anna ^a   Pizzichemi, Giuseppe ^a   Nobili, Valerio ^a   De Ville De Goyet, Jean ^a   Torre, Guiliano ^a  

^a BAMBINO GESÙ CHILDREN S HOSPITAL   (Italy)

Author keywords

fulminant liver failure; hepatitis B; infant; tenofovir

Indexed keywords

ACETYLCYSTEINE; AMMONIA; ANTIBIOTIC AGENT; FRESH FROZEN PLASMA; HEPATITIS B SURFACE ANTIGEN; HEPATITIS B VACCINE; LACTULOSE; PROTHROMBIN; TENOFOVIR; TENOFOVIR DISOPROXIL; VITAMIN K GROUP;

AGITATION; AMMONIA BLOOD LEVEL; ANOREXIA; ANTIBIOTIC THERAPY; ARTICLE; ASTHENIA; BRAIN DISEASE; CASE REPORT; ELECTROENCEPHALOGRAPHY; FEMALE; HEPATITIS B; HUMAN; INFANT; INFANT DISEASE; JAUNDICE; LIVER TRANSPLANTATION; PHYSICAL EXAMINATION; POLYMERASE CHAIN REACTION; PRIORITY JOURNAL; SOMNOLENCE; THROMBOCYTOPENIA; TREATMENT OUTCOME;

EID: 80052949868     PISSN: 08913668     EISSN: 15320987     Source Type: Journal    
DOI: 10.1097/INF.0b013e31821e23b3     Document Type: Article

References (19)

1. Bernal W, Auzinger G, Dhawan A, et al. Acute liver failure. Lancet. 2010;376:190-201.
2. Lee WS, McKiernan P, Kelly DA. Etiology, outcome and prognostic indicators of childhood fulminant hepatic failure in the United Kingdom. J Pediatr Gastroenterol Nutr. 2005;40:575-581. (Pubitemid 40617185)
3. Chen HL, Chang CJ, Kong MS, et al. Pediatric fulminant hepatic failure in endemic areas of hepatitis B infection: 15 years after universal hepatitis B vaccination. Hepatology. 2004;39:58-63.
4. Beath SV, Boxall EH, Watson RM, et al. Fulminant hepatitis B in infants born to anti-HBe hepatitis B carrier mothers. BMJ. 1992;304:1169-1170.
5. Jonas MM, Block JM, Haber BA, et al. Treatment of children with chronic hepatitis B virus infection in the United States: patient selection and therapeutic options. Hapatology. 2010;52:2192-2205.
6. Jonas MM, Kelley DA, Mizerski J, et al. Clinical trial of lamivudine in children with chronic hepatitis B. N Engl J Med. 2002;346:1706-1713. (Pubitemid 34547484)
7. Sokal EM, Kelly DA, Mizerski J, et al. Long-term lamivudine therapy for children with HBe-Ag-positive chronic hepatitis B. Hepatology. 2006;43: 225-232.
8. Jonas MM, Little NR, Gardner SD; International Pediatric Lamivudine Investigator Group. Long-term lamivudine treatment of children with chronic hepatitis B: durability of therapeutic responses and safety. J Viral Hepat. 2008;15:20-27. (Pubitemid 350243578)
9. Roussos A, Koilakou S, Kalafatas I, et al. Lamivudine treatment for acute severe hepatitis B: report of a case and review of the literature. Acta Gastroenterol Belg. 2008;71:30-32. (Pubitemid 351613483)
10. Chen CY, Ni YH, Chen HL, et al. Lamivudine treatment in infantile fulminant hepatitis B. Pediatr Int. 2010;52:672-674.
11. Laubscher B, Gehri M, Roulet M, et al. Survival of infantile fulminant hepatitis B and treatment with lamivudine. J Pediatr Gastroenterol Nutr. 2005;40:518-520. (Pubitemid 40489584)
12. Wang YM, Tang YZ. Antiviral therapy for hepatitis B virus associated hepatic failure. Hepatobiliary Pancreat Dis Int. 2009;8:17-24.
13. Vanclaire J, Cornu C, Sokal EM. Fulminant hepatitis B in an infant born to a hepatitis Be antibody positive, DNA negative carrier. Arch Dis Child. 1991;66:983-985.
14. Lok AS. Drug therapy: Tenofovir. Hepatology. 2010;52:743-747.
15. Rots NY, Wijmenga-Monsuur AJ, Luytjes W, et al. Hepatitis B vaccination strategies tailored to different endemicity levels: some considerations. Vaccine. 2010;28:893-900.
16. Fischer G, Wang S, Ahring S, et al. An investigation of perinatal hepatitis B virus infections among a high risk population: the delivery hospital as a safety net. Ped Infect Dis J. 2009;28:593-597.
17. Mele A, Tosti ME, Mariano A, et al. National Surveillance System for Acute Viral Hepatitis (SEIEVA) Collaborating Group. Acute hepatitis B: 14 years after the implementation of universal vaccination in Italy: areas of improvement and emerging challenges. Clin Infect Dis. 2008; 46:868-875. (Pubitemid 351417188)
18. Lee WM. Hepatitis B virus infection. N Engl J Med. 1997;337:1733-1745. (Pubitemid 27527771)
19. Gafni RI, Hazra R, Reynolds JC, et al. Tenofovir disoproxil fumarate and an optimized background regimen of antiretroviral agents as salvage therapy: impact on bone mineral density in HIV-infected children. Pediatrics. 2006;118:e711-e718. (Pubitemid 46089998)